This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2016
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2016
Industry Economic Analysis
$645.00
Research and Development—R&D spending as a share of total sales continues to decline, which may keep Canadian firms from capitalizing on rising demand from aging populations in the higher-margin patented drug market.
International Trade—Canadian exports of pharmaceutical products are booming. New free trade agreements with the EU and Pacific Rim countries will increase access to more foreign markets for Canadian firms.
U.S. Legislation—The U.S. Affordable Health Care Act has increased the number of Americans covered by drug plans, boosting demand in a high-price environment for Canadian drugs.
Customers Who Downloaded This Also Liked
6 min read
10 min read
10 min read
10 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
